Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message|
( followers)  

Do you follow smart money buying trends? For a closer look at stocks currently favored by smart money institutional investors and company insiders, we ran a screen you may be interested in.

We began by screening for stocks with high growth projections, with 5-year projected EPS growth rates above 15%.

We then screened these names for those with the confidence of their company insiders, such as members of the board and upper management, with significant net insider purchases over the last six months representing at least 2% of share float. Since most companies only have a handful of company insiders, net insider purchases representing 2% of share float is a big show of confidence in their employer's prospects.

We then screened for those with bullish sentiment from institutional investors as well, with significant net institutional purchases over the last quarter representing at least 5% of share float. This indicates that institutional investors such as hedge fund managers and mutual fund managers expect these names to outperform.

Interactive Chart: Press Play to compare changes in market cap over the last two years for the stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.

We also created a price-weighted index of the stocks mentioned below, and monitored the performance of the list relative to the S&P 500 index over the last month. To access a complete analysis of this list's recent performance, click here.

Do you think these companies will reach their high growth projections? Use this list as a starting point for your own analysis.

List sorted by net insider purchases over the last six months as a percent of share float.

1. China Biologic Products, Inc. (NASDAQ:CBPO): Engages in the research, development, manufacturing, and sale of plasma-based pharmaceutical products. Market cap at $225.79M, most recent closing price at $8.85. 5-year projected EPS growth at 30.00%. Net institutional purchases in the current quarter at 718.3K shares, which represents about 10.37% of the company's float of 6.93M shares. Over the last six months, insiders were net buyers of 795,860 shares, which represents about 11.48% of the company's 6.93M share float.

2. Horizon Pharma, Inc. (NASDAQ:HZNP): Develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. Market cap at $121.66M, most recent closing price at $3.54. 5-year projected EPS growth at 20.00%. Net institutional purchases in the current quarter at 2.3M shares, which represents about 9.07% of the company's float of 25.35M shares. Over the last six months, insiders were net buyers of 1,511,150 shares, which represents about 5.96% of the company's 25.35M share float.

3. Genomic Health Inc. (NASDAQ:GHDX): Focuses on the development and global commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Market cap at $876.26M, most recent closing price at $29.38. 5-year projected EPS growth at 42.67%. Net institutional purchases in the current quarter at 3.0M shares, which represents about 10.89% of the company's float of 27.54M shares. Over the last six months, insiders were net buyers of 744,007 shares, which represents about 2.7% of the company's 27.54M share float.

4. Sunrise Senior Living Inc. (SRZ): Provides senior living services in the United States, Canada, the United Kingdom, and Germany. Market cap at $382.31M, most recent closing price at $6.58. 5-year projected EPS growth at 18.00%. Net institutional purchases in the current quarter at 2.2M shares, which represents about 5.31% of the company's float of 41.44M shares. Over the last six months, insiders were net buyers of 916,790 shares, which represents about 2.21% of the company's 41.44M share float.

*Insider data sourced from Yahoo! Finance, institutional data sourced from Fidelity, all other data sourced from Finviz.

Source: 4 High-Growth Stocks Being Bought Up By Hedge Funds And Company Insiders